Position in BIIB
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$52,092,282
+$4,658,395 QoQ
Shares Held
241,101
-6.8% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#1
of 66 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 98.76649205104914.ToString("F0")%
Shared 0.ToString("F0")%
None 1.2335079489508547.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAMES CAPITAL plc holds $1,010,877,249 across 9 Drug Manufacturers - General names. BIIB ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,905,111 | $361,247,147 | |
| 2 | ABBV |
AbbVie Inc.
|
680,730 | $171,298,897 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,169,722 | $150,309,277 | |
| 4 | JNJ |
Johnson & Johnson
|
443,703 | $112,687,250 | |
| 5 | LLY |
ELI LILLY & Co
|
81,026 | $97,185,023 | |
| 6 | BIIB |
Biogen Inc.
This page
|
241,101 | $52,092,282 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
635,252 | $36,603,220 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
192,146 | $24,275,725 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,092,282 | 241,101 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $47,433,887 | 258,735 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $45,785,910 | 260,162 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $27,404,550 | 195,635 | Shares | Sole | 2025-10-31 | |
| 2020-12-31 | $1,569,552 | 6,410 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $10,088,228 | 35,562 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $34,227,136 | 127,928 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $40,492,527 | 127,987 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||